The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I previously listed the slow selling of the previous directors. Will be in my posting history. Just ignore the moaning about EUA 🫤
I believe if they have finished and wish to hold what’s left then the brakes may come off and we may see good uplift. The fact the SP hasn’t reacted badly and is above the placing is also good news imo.
This could well be another unicorn like ARB was, but hopefully better management.
The carrot of end of year sale was dangled yet again. this time by the company themselves. The same carrot is trotted out every year. The only use for it is as the nose of a snowman. A snowman that sadly melts away to nothing, leaving only the carrot on the ground in a damp puddle of hopes and dreams. The carrot is then picked up and put away for next time.
Tick tock worst BOD on AIM.
MM wasn't the first to buy stakes in Kelso, the other companies that Kelso invested in have also bought shares. 3% ish I believe. It's a standard defence tactic.
If MM gets to 10%, I think he can insist on joining the Kelso board. That would be fun to see.
Fulmar and stopleb, my post was merely a cut and paste of a report on trading view. These are usually supplied by Dow Jones newswire, Reuters or some other credible source.
At the time I posted it AAL were down 12% on the day.
This new to me information and the reaction on the share price of AAL was not being mentioned on here. But it is factual, so don’t shoot the messenger.
People can do what they like with any facts presented to them. But today I decided to sell my remaining 250k arcm shares at a considerable loss because I believe AAL will hold back on development here. That is only my opinion. Take it as a deramp if you like, I don’t care.
Owning this share has been hard work for the last three years, I will move the remaining cash from this into something with stronger prospects not on AIM.
Good luck to holders, hope it comes good.
Anglo American on Friday outlined plans to drastically reduce its mining output between now and 2026 with a view to saving $1.8 billion in costs as plunging commodity prices have eaten into its profits.
The plans will see the mining giant slash production of diamonds and platinum group metals (PGMs) and scale back its copper and iron ore mines in Chile and South Africa that have been plagued by rising costs and operational issues.
Shares in Anglo American (UK:AAL) fell 5% on Friday having lost 35% of their value over the previous 12 months.
"Whilst it is clearly not positive that Anglo has come to this situation where it needs to shrink its footprint, we think this new streamlined Anglo American should allow it to shed some of the recently more challenging aspects of the business and addressing this proactively should help the company emerge in a stronger position for the coming years," RBC analysts led by Tyler Broda said
The miner's cost-cutting plans will see it cut production at its huge Kumba iron ore mine in South Africa and reduce its operations to just a single plant at its 156-year-old Los Bronces Copper mine in Chile by closing the older of its two facilities at the site.
The cuts will see Anglo American slash its production by 7% over the next two years, with the sharpest reductions in its output of copper.